Aurinia Pharmaceuticals (AUPH) Other Gross PP&E Adjustments (2018 - 2025)
Historic Other Gross PP&E Adjustments for Aurinia Pharmaceuticals (AUPH) over the last 10 years, with Q3 2025 value amounting to -$73.5 million.
- Aurinia Pharmaceuticals' Other Gross PP&E Adjustments rose 1934.97% to -$73.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$73.5 million, marking a year-over-year increase of 1934.97%. This contributed to the annual value of -$86.8 million for FY2024, which is 1608.78% up from last year.
- Aurinia Pharmaceuticals' Other Gross PP&E Adjustments amounted to -$73.5 million in Q3 2025, which was up 1934.97% from -$77.9 million recorded in Q2 2025.
- Aurinia Pharmaceuticals' 5-year Other Gross PP&E Adjustments high stood at $477000.0 for Q1 2023, and its period low was -$112.2 million during Q2 2023.
- Over the past 5 years, Aurinia Pharmaceuticals' median Other Gross PP&E Adjustments value was -$73.5 million (recorded in 2025), while the average stood at -$49.0 million.
- Within the past 5 years, the most significant YoY rise in Aurinia Pharmaceuticals' Other Gross PP&E Adjustments was 38181.82% (2023), while the steepest drop was 8847622.95% (2023).
- Quarter analysis of 5 years shows Aurinia Pharmaceuticals' Other Gross PP&E Adjustments stood at -$129000.0 in 2021, then surged by 253.49% to $198000.0 in 2022, then crashed by 52347.98% to -$103.5 million in 2023, then rose by 16.09% to -$86.8 million in 2024, then grew by 15.27% to -$73.5 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$73.5 million for Q3 2025, versus -$77.9 million for Q2 2025 and -$82.3 million for Q1 2025.